Exercise Preserves CV Function in Breast Cancer Patients Exercise Preserves CV Function in Breast Cancer Patients
A structured exercise program during treatment helps preserve cardiovascular function in breast cancer patients at both 6 and 12 months compared with standard care.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 10, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Why anyone who is serious about preventing cancer should start drinking wheatgrass every single day
(Natural News) Wheatgrass is the darling of holistic medicine. Natural healers praise wheatgrass for its numerous health benefits, one of which is its extraordinary ability to prevent cancer. While the green shade may be off-putting to some, we’ve listed down three reasons why wheatgrass should be part of your everyday eating plan, especially if you are... (Source: NaturalNews.com)
Source: NaturalNews.com - December 10, 2018 Category: Consumer Health News Source Type: news

Compounds found in guava observed to display potent anticancer activity
(Natural News) Guava is more than just a delicious tropical fruit. In regions where it is grown, it is also recognized as a potent medicinal plant. One study confirms that guava possesses powerful natural compounds, some of which give the fruits anti-cancer effects. The researchers tested various extracts of guava (methanol, hexane, and chloroform) on... (Source: NaturalNews.com)
Source: NaturalNews.com - December 10, 2018 Category: Consumer Health News Source Type: news

Atezolizumab Now Also Approved for Front-Line NSCLC Atezolizumab Now Also Approved for Front-Line NSCLC
The immunotherapy has received FDA approval for an expanded indication for use in combination in nonsmall cell lung cancer.News Alerts (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 10, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news

Women with HPV at higher cervical cancer risk, regardlesss of cell abnormalities
Women with HPV may be at higher risk for cervical cancer, but appear not to show cellular abnormalities, report researchers in Sweden. (Source: Health News - UPI.com)
Source: Health News - UPI.com - December 10, 2018 Category: Consumer Health News Source Type: news

An overview of renal cell carcinoma
RCC is the seventh leading cause of cancer deaths in the U.S. Check out this article for an overview of the condition.12/10/2018 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - December 10, 2018 Category: Urology & Nephrology Source Type: news

Breast Cancer Testing Guidelines Outdated, Study Says
By Susan Scutti, CNN (CNN) — The current guidelines for genetic testing of breast cancer patients limit the number of women who can get tested. Because of these restrictions, these tests miss as many patients with hereditary cancers as they find, according to a study published Monday in the Journal of Clinical Oncology. “Unfortunately, insurance companies pay attention to these guidelines,” said Dr. Peter Beitsch, co-author of the study and a cancer surgeon practicing in Texas. Insurance companies and other payers reimburse genetic testing — or not — based on the guidelines. The...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - December 10, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News Breast Cancer CNN Source Type: news

UK donor found for Florida girl, 2, fighting cancer with rare blood type found in specific gene pool
Zainab Mughal, two, from South Florida, needs life-saving transfusions but she has a very rare blood type that makes finding donors difficult. A 50-year-old mother from the UK was found to be a match. (Source: the Mail online | Health)
Source: the Mail online | Health - December 10, 2018 Category: Consumer Health News Source Type: news

Merck KGaA, Darmstadt, Germany Announces FDA Orphan Drug Designation for Bifunctional Immunotherapy M7824 in Biliary Tract Cancer
FDA grants M7824, an investigational bifunctional immunotherapy, orphan drug designation in biliary tract cancer First regulatory designation for M7824 following recent presentation of first clinical data in BTC BTC is a group of rare, aggressive g... Biopharmaceuticals, Oncology, FDA Merck KGaA, Immunotherapy, M7824, Biliary Tract Cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 10, 2018 Category: Pharmaceuticals Source Type: news

AstraZeneca partners on cancer tech center
AstraZeneca announced a new collaboration with Cancer Research UK to launch a center of excellence in genetic screening, cancer modeling and big data processing (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - December 10, 2018 Category: Pharmaceuticals Source Type: news

Are male doctors too complacent about the cancer pill many women say is ruining their lives?  
Tamoxifen is a daily pill taken by about 550,000 British breast cancer survivors. It can slash their risk of recurrence after treatment by up to 45 per cent. (Source: the Mail online | Health)
Source: the Mail online | Health - December 10, 2018 Category: Consumer Health News Source Type: news

Breast cancer testing guidelines out of date, missing genetic screening
The current guidelines for genetic testing of breast cancer patients limit the number of women who can get tested. Because of these restrictions, these tests miss as many patients with hereditary cancers as they find, according to a study published Monday in the Journal of Clinical Oncology. (Source: CNN.com - Health)
Source: CNN.com - Health - December 10, 2018 Category: Consumer Health News Source Type: news

New Study Published in Journal of Clinical Oncology Supports Universal Genetic Testing for all Breast Cancer Patients
Data shows current guidelines exclude many patients with medically relevant genetic changes SAN FRANCISCO, Dec. 10, 2018 -- (Healthcare Sales & Marketing Network) -- Current guidelines for genetic testing of breast cancer patients miss as many patients... Diagnostics, Oncology Invitae Corp, TME Breast Care Network, BRCA1, BRCA2 (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 10, 2018 Category: Pharmaceuticals Source Type: news

CStone Pharmaceuticals Appoints Former MSD Global Oncology Early Development Executive Director Archie Tse, M.D., Ph.D., as the newly established SVP, Chief Translation Medicine Officer
Dr. Tse's Extensive Track Record in Oncology Early Clinical Development Will Strengthen CStone's Core Competence as a Clinical Development Engine and Solidify CStone's Position Among Leading Innovative Biopharma Companies in China SUZHOU, China, Dec. 10... Biopharmaceuticals, Oncology, Personnel CStone Pharmaceuticals (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 10, 2018 Category: Pharmaceuticals Source Type: news

' It's Going to Be a Useful Agent': Oxybutynin for Hot Flashes'It's Going to Be a Useful Agent': Oxybutynin for Hot Flashes
A urinary incontinence drug is surprisingly effective in the treatment of hot flashes for both women with a history of breast cancer and those with menopausal symptoms but who do not have cancer.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 10, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Oxybutynin can reduce hot flashes in breast cancer survivors
Research, presented at the San Antonio Breast Cancer Symposium, suggests that the drug oxybutynin can reduce the severity of hot flashes in patients who have had breast cancer. Healio (Source: Society for Endocrinology)
Source: Society for Endocrinology - December 10, 2018 Category: Endocrinology Source Type: news

Over a million people DIE from chemotherapy every year, but only 750,000 pass away from cancer – what's WRONG with this picture?
(Natural News) Chemical warfare on humanity was launched nearly a century ago by the American Medical Association when they eliminated nutrition classes from medical colleges and approval-stamped any chemical medication that came down the pike as the drug of choice for whatever ailment any doctor chose to manage for their “patients for life.” Then came... (Source: NaturalNews.com)
Source: NaturalNews.com - December 10, 2018 Category: Consumer Health News Source Type: news

Modified citrus pectin can inhibit the growth and metastasis of prostate cancer and kill leukemia cells
(Natural News) Prostate cancer is the second most common cancer among American men, and statistics indicate that there are over two million prostate cancer survivors currently living in the United States. It is most common in men over the age of 65 and is rated as the second most common cause of cancer-related death in... (Source: NaturalNews.com)
Source: NaturalNews.com - December 10, 2018 Category: Consumer Health News Source Type: news

How drinking coffee reduces cancer risk
(Natural News) Many people can’t survive without the energy boost that their morning coffee provides. But if you’re not one of those people, there are many other reasons why you should start getting your daily dose of coffee. A review paper, which was published in the journal Scientific Reports, revealed that drinking coffee significantly reduces the risk... (Source: NaturalNews.com)
Source: NaturalNews.com - December 10, 2018 Category: Consumer Health News Source Type: news

Roche vet named Gilead CEO — and Genentech boss moves to Switzerland — in shuffle of top Bay Area biotech execs
Gilead Sciences Inc. landed former Roche executive Daniel O'Day as its new CEO, and Genentech Inc.'s current CEO will take O'Day's role with Genentech's parent company in a game of musical chairs disclosed Sunday. The job shuffling has implications up and down the employment ranks of the Bay Area's two largest drug makers during critical times for both companies. Gilead (NASDAQ: GILD), based in Foster City, is set up for deeper moves into next-generation cancer drugs while South San Francisco's… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - December 10, 2018 Category: American Health Authors: Ron Leuty Source Type: news

Roche vet named Gilead CEO — and Genentech boss moves to Switzerland — in shuffle of top Bay Area biotech execs
Gilead Sciences Inc. landed former Roche executive Daniel O'Day as its new CEO, and Genentech Inc.'s current CEO will take O'Day's role with Genentech's parent company in a game of musical chairs disclosed Sunday. The job shuffling has implications up and down the employment ranks of the Bay Area's two largest drug makers during critical times for both companies. Gilead (NASDAQ: GILD), based in Foster City, is set up for deeper moves into next-generation cancer drugs while South San Francisco's… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 10, 2018 Category: Biotechnology Authors: Ron Leuty Source Type: news

AstraZeneca and Cancer Research UK launch Functional Genomics Centre to accelerate the discovery of new medicines
AstraZeneca today announced a new collaboration with Cancer Research UK to launch a centre of excellence in genetic screening, cancer modelling and big data processing aimed at accelerating the discovery of new cancer medicines. The Functional Genomics Centre will further develop CRISPR technology to better understand the biology of cancer, (Source: World Pharma News)
Source: World Pharma News - December 10, 2018 Category: Pharmaceuticals Tags: Featured AstraZeneca Business and Industry Source Type: news

Transplanted organs gave patients cancer
Two people developed cancer after organ donations from a woman who had the undetected disease. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - December 10, 2018 Category: Consumer Health News Source Type: news

Calling the Shots?
The USA has the highest drug costs in the world, and they are increasing at the fastest rate too. With one in five Americans saying they have been forced to leave a prescription unfilled due to high costs, the situation is clearly unsustainable.Payers and pharmacy benefit managers (PBMs), themselves facing increased criticism for blocking access to important medicines, are taking action by demanding that pharma companies justify the cost – and value – of their new medicines.“There is a point where a government, an employer or a healthcare plan has a finite amount of resources to spend,” says Brian H...
Source: EyeForPharma - December 10, 2018 Category: Pharmaceuticals Authors: Katie Osborne Source Type: news

Tanzania: Cancer Prevention, Awareness Facility Expands Scope
[Daily News] THE Cancer Prevention and Awareness Camp (PrevAcamp) has expanded its scope having this time pitched a camp at Arusha Lutheran Medical Centre (ALMC) at the weekend. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - December 10, 2018 Category: African Health Source Type: news

More Blood Pressure Meds Recalled Due to Carcinogen
Title: More Blood Pressure Meds Recalled Due to CarcinogenCategory: Health NewsCreated: 12/7/2018 12:00:00 AMLast Editorial Review: 12/10/2018 12:00:00 AM (Source: MedicineNet High Blood Pressure General)
Source: MedicineNet High Blood Pressure General - December 10, 2018 Category: Cardiology Source Type: news

Excess Body Fat May Increase Older Women's Breast Cancer Risk: Study
Title: Excess Body Fat May Increase Older Women's Breast Cancer Risk: StudyCategory: Health NewsCreated: 12/7/2018 12:00:00 AMLast Editorial Review: 12/10/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - December 10, 2018 Category: Cancer & Oncology Source Type: news

Cianna touts SAVI Scout results at SABCS
At this week's San Antonio Breast Cancer Symposium (SABCS), breast tumor localization...Read more on AuntMinnie.comRelated Reading: Merit Medical wraps up purchase of Cianna Medical Merit Medical to acquire Cianna Medical FDA OKs Cianna's Scout for soft-tissue localization Cianna marks SAVI Scout milestone Cianna debuts ScoutCare program (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 10, 2018 Category: Radiology Source Type: news

Black women have worse breast cancer outcomes
Black women have higher breast cancer recurrence and overall mortality compared...Read more on AuntMinnie.comRelated Reading: Patient navigators help black women with mammograms ACR, SBI: Some black women need earlier breast screening Race matters for breast cancer screening protocols Gap narrows in black, white breast cancer death rates USPSTF: Why do more black women die from breast cancer? (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 10, 2018 Category: Radiology Source Type: news

Improving Work Outcomes Among Cancer Survivors Improving Work Outcomes Among Cancer Survivors
Training programs are needed to help employers improve communication with cancer survivors and facilitate workplace accommodations.Journal of the National Cancer Institute (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 10, 2018 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Utility of Genomic Profiling in Treating Advanced Sarcomas Utility of Genomic Profiling in Treating Advanced Sarcomas
Molecular profiling may be particularly useful in guiding therapy of sarcoma with an unclear diagnosis or rare subtype.JCO Precision Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 10, 2018 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

RAI-Related Clonal Hematopoiesis in Thyroid Cancer RAI-Related Clonal Hematopoiesis in Thyroid Cancer
This study explores the prevalence of clonal hematopoiesis related to radioactive iodine exposure and how it impacts overall survival in patients with thyroid cancer.Journal of Clinical Endocrinology & Metabolism (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 10, 2018 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news

Biological Therapy and Cancer Risk in Patients With Psoriasis Biological Therapy and Cancer Risk in Patients With Psoriasis
Does long-term exposure to systemic immunomodulatory therapies increase the risk of cancer in patients with psoriasis?The British Journal of Dermatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 10, 2018 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news

Increased risk for breast cancer after childbirth may last more than 20 years
(American College of Physicians) The increased risk for breast cancer that occurs after childbirth can last more than 20 years. The risk may be enhanced when a woman is older at first birth or has a family history of breast cancer, and is not mitigated by breastfeeding. Findings from pooled analysis of 15 prospective studies are published in Annals of Internal Medicine. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 10, 2018 Category: Cancer & Oncology Source Type: news

Study finds higher risk of breast cancer for women after giving birth
(UNC Lineberger Comprehensive Cancer Center) Researchers from the Premenopausal Breast Cancer Collaborative Group identified elevated breast cancer risk after childbirth in women younger than 55. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 10, 2018 Category: Cancer & Oncology Source Type: news

Death rates from cancer will fall in Australasian countries and Russia in 2018
(European Society for Medical Oncology) Researchers predict that death rates from cancer will fall in 2018 in Australasian countries and in Russia. However, a greater proportion of the population will die in Russia from the disease than in any of the other countries, mainly because of the large numbers of men who still smoke. The study is published in Annals of Oncology. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 10, 2018 Category: Cancer & Oncology Source Type: news

Some brain tumors may respond to immunotherapy, new study suggests
(Columbia University Irving Medical Center) A new study suggests that a slow-growing brain tumor arising in patients affected by neurofibromatosis type 1 (NF1) may be vulnerable to immunotherapy, which gives the immune system a boost in fighting cancer. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 10, 2018 Category: International Medicine & Public Health Source Type: news

Sprayable gel could help the body fight off cancer after surgery
(University of California - Los Angeles Health Sciences) A UCLA-led research team has developed a spray gel embedded with immune-boosting drugs that could help lower the risk of cancer recurrence after surgery. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 10, 2018 Category: International Medicine & Public Health Source Type: news

Researchers image atomic structure of important immune regulator
(Brigham and Women's Hospital) A new study by investigators from Brigham and Women's Hospital provides a biophysical and structural assessment of a critical immune regulating protein called human T-cell immunoglobulin and mucin domain containing protein-3 (hTIM-3). Understanding the atomic structure of hTIM-3 provides new insights for targeting this protein for numerous cancer and autoimmune therapeutics currently under clinical development. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 10, 2018 Category: International Medicine & Public Health Source Type: news

MD Anderson study shows key enzyme linked to therapy resistance in deadly lung cancer
(University of Texas M. D. Anderson Cancer Center) Researchers at The University of Texas MD Anderson Cancer Center have identified a link between an enzyme tied to cancer formation and therapy resistance in patients with epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC). They believe two existing therapies may hold promise for clinical studies for this deadly and common lung cancer for which relapse often occurs within one year following treatment. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 10, 2018 Category: Cancer & Oncology Source Type: news

Media Advisory: Young age associated with worse prognosis in specific breast cancer subtype
(Johns Hopkins Medicine) Researchers at Johns Hopkins Kimmel Cancer Center are rapidly advancing the understanding of biological factors, including hormones, as predictors of longer disease-free survival for certain subtypes of breast cancer. The implications for treatment -- especially among younger women -- can be profound, but uncertainties remain and decision-making by patients and their physicians can be complicated. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 10, 2018 Category: Cancer & Oncology Source Type: news

How does cancer spread?
(McGill University Health Centre) How does cancer spread? While studying human brain tumour cells, a team of scientists at the Research Institute of the McGill University Health Centre (RI-MUHC) found some answers to this crucial, yet so far unanswered question. They looked at a gene called EGFRvIII, which is present in patients with glioblastoma -- a highly aggressive form of brain cancer that spreads quickly and that is difficult to treat. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 10, 2018 Category: Cancer & Oncology Source Type: news

Cancer cells distinguished by artificial intelligence-based system
(Osaka University) A research team at Osaka University created a system that uses a convolutional neural network to learn the features distinguishing different cancer cells, based on images from a phase-contrast microscope. This system accurately differentiated human and mouse cancer cells, as well as their radioresistant clones. This novel approach can improve the speed and accuracy of cancer diagnosis by avoiding the laboriousness and potential errors associated with equivalent analyses by humans. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 10, 2018 Category: Cancer & Oncology Source Type: news

New insights into childhood cancer
(Charit é - Universit ä tsmedizin Berlin) Peripheral nervous system tumors, known as neuroblastoma, are one of the most common types of childhood tumors. As part of an international research endeavor, researchers from Charit é - Universit ä tsmedizin Berlin have studied the genetic factors behind different tumor subtypes and their prognoses. Their findings enable clinicians to predict the precise clinical course of the disease, and to adapt their treatment regimens accordingly. The study has been published in the prestigious journal Science*. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 10, 2018 Category: Cancer & Oncology Source Type: news

Breast cancer recruits bone marrow cells to increase cancer cell proliferation
(American Friends of Tel Aviv University) Tel Aviv University researchers have discovered that breast cancer tumors boost their growth by recruiting stromal cells that originate in bone marrow. The study suggests that targeting these cells with new therapies could be an effective way of treating the disease. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 10, 2018 Category: Cancer & Oncology Source Type: news

Interplay between MicroRNAs and targeted genes in cellular homeostasis of adult zebrafish
The objective of study was to understand the damages induced by toxins in the liver and the intestine as well as the interplay between the miRNome and transcriptome baseline characterization in these tissues in healthy animals under cellular homeostasis. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 10, 2018 Category: Cancer & Oncology Source Type: news

Researchers develop personalized medicine tool for inherited colorectal cancer syndrome
(Huntsman Cancer Institute) An international team of researchers led by Huntsman Cancer Institute (HCI) at the University of Utah (U of U) has developed, calibrated, and validated a novel tool for identifying the genetic changes in Lynch syndrome genes that are likely to be responsible for causing symptoms of the disease. The results were published this week in the journal Genetics in Medicine. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 10, 2018 Category: Cancer & Oncology Source Type: news

Increased cervical cancer risk in women with positive HPV, but no cellular abnormalities
(Wiley) Researchers have uncovered an increased risk of cervical cancer in women whose cervical cells test positive for certain high-risk human papillomavirus (HPV) types but do not show any signs of cellular abnormalities. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings may help refine guidelines for cervical cancer screening. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 10, 2018 Category: Cancer & Oncology Source Type: news

Breast cancer screening: New emphasis on shared decision-making between women and their doctors
(Canadian Medical Association Journal) An updated guideline on screening for breast cancer emphasizes shared decision-making between women and their doctors, supporting women to make an informed decision based on personal preferences when the balance between benefits and harms is uncertain. The guideline, released by the Canadian Task Force on Preventive Health Care, is published in CMAJ (Canadian Medical Association Journal). (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 10, 2018 Category: Cancer & Oncology Source Type: news

#MayoClinicRadio podcast: 12/8/18
Listen: Mayo Clinic Radio 12/8/18 On the Mayo Clinic Radio podcast, Dr. John Kisiel, a gastroenterologist at Mayo Clinic, discusses screening, treatment and prevention of colorectal cancer.?Also on the podcast, Dr. Matthew Ferber, a medical geneticist at Mayo Clinic, explains?Mayo Clinic GeneGuide. GeneGuide is the new personal DNA product backed by Mayo medical science and [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - December 10, 2018 Category: Databases & Libraries Source Type: news